NYSEARCA:MLSS - NYSE Arca - US59935P2092 - Common Stock - Currency: USD
NYSEARCA:MLSS (2/21/2025, 8:04:00 PM)
1.04
-0.05 (-4.59%)
The current stock price of MLSS is 1.04 USD. In the past month the price decreased by -20%. In the past year, price increased by 50.72%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. The company is headquartered in Livingston, New Jersey and currently employs 17 full-time employees. The firm patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The firm operates through two segments: dental and medical. The firm has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.
MILESTONE SCIENTIFIC INC
220 S Orange Ave
Livingston NEW JERSEY 07068 US
CEO: Leonard Osser
Employees: 17
Company Website: https://www.milestonescientific.com/
Investor Relations: http://www.milestonescientific.com/investors
Phone: 19735352717
The current stock price of MLSS is 1.04 USD. The price decreased by -4.59% in the last trading session.
The exchange symbol of MILESTONE SCIENTIFIC INC is MLSS and it is listed on the NYSE Arca exchange.
MLSS stock is listed on the NYSE Arca exchange.
8 analysts have analysed MLSS and the average price target is 2.17 USD. This implies a price increase of 108.41% is expected in the next year compared to the current price of 1.04. Check the MILESTONE SCIENTIFIC INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MILESTONE SCIENTIFIC INC (MLSS) has a market capitalization of 81.01M USD. This makes MLSS a Micro Cap stock.
MILESTONE SCIENTIFIC INC (MLSS) currently has 17 employees.
MILESTONE SCIENTIFIC INC (MLSS) has a support level at 0.7 and a resistance level at 1.24. Check the full technical report for a detailed analysis of MLSS support and resistance levels.
The Revenue of MILESTONE SCIENTIFIC INC (MLSS) is expected to decline by -12.34% in the next year. Check the estimates tab for more information on the MLSS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MLSS does not pay a dividend.
MILESTONE SCIENTIFIC INC (MLSS) will report earnings on 2025-03-27, after the market close.
MILESTONE SCIENTIFIC INC (MLSS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.06).
The outstanding short interest for MILESTONE SCIENTIFIC INC (MLSS) is 0.22% of its float. Check the ownership tab for more information on the MLSS short interest.
ChartMill assigns a technical rating of 8 / 10 to MLSS. When comparing the yearly performance of all stocks, MLSS is one of the better performing stocks in the market, outperforming 93.33% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to MLSS. The financial health of MLSS is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months MLSS reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS increased by 40.25% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -41.31% | ||
ROE | -63.93% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 83% to MLSS. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 37.5% and a revenue growth -12.34% for MLSS